warnings
Warnings - For external use only. - Avoid contact with eyes.
Lidozall Pro
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Lidozall Pro
- Generic name
- LIDOCAINE HYDROCHLORIDE
- Manufacturer
- V2 Pharma LLC
- Product type
- HUMAN OTC DRUG
- SPL set ID
- ecc26ba7-4ff6-43e6-bfb9-91a9cbb509ff
- SPL ID
- ef3aeded-ab30-4b42-ab71-d5aa7c0fbd60
- Version
- 1
- Effective date
- 2026-06-16
- Source export date
- 2026-09-28
- Source partition
- 11
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/aa96b5a2be6b394393acd0090f6948bdf99e0e8e00666f81608929c8fa83db77/drug-label-0011-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 06:17:54
| Harmonized routes |
|---|
| TOPICAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application number | M017 | openfda.application_number | |
| brand name | Lidozall Pro | openfda.brand_name | |
| generic name | LIDOCAINE HYDROCHLORIDE | openfda.generic_name | |
| manufacturer name | V2 Pharma LLC | openfda.manufacturer_name | |
| ndc | package | 72835-445-05 | openfda.package_ndc |
| ndc | product | 72835-445 | openfda.product_ndc |
| ndc11 | package | 72835044505 | derived:openfda.package_ndc |
| rxcui | 1010895 | openfda.rxcui | |
| spl id | ef3aeded-ab30-4b42-ab71-d5aa7c0fbd60 | id | |
| spl set id | ecc26ba7-4ff6-43e6-bfb9-91a9cbb509ff | set_id | |
| unii | V13007Z41A | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.